Variant Bio

Seattle, United States

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Nov 2021

Series B

Top Investors

General CatalystLux CapitalCasdin CapitalAlexandria Venture InvestmentsSoftBank Vision Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Variant Bio's investors?

Variant Bio's investors include General Catalyst, Lux Capital, Casdin Capital, Alexandria Venture Investments, SoftBank Vision Fund.

Where is Variant Bio headquartered?

Variant Bio is headquartered in Seattle, United States.

What does Variant Bio do?

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

What stage is Variant Bio at?

Variant Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 9, 2021.

MLA

"Variant Bio — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/variant-bio. Accessed July 1, 2026.

APA

VCBacked. (2021). Variant Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/variant-bio

Wikipedia (cite web)

{{cite web |title=Variant Bio — Funding & Investors |url=https://www.vcbacked.co/company/variant-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 9, 2021.